Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Evolus Inc
EOLSCurrent price
16.75 USD
+0.31 USD (+1.87%)
Last closed
16.32 USD
Company
www.evolus.com
ISIN
US30052C1071
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
1 038 535 424 USD
Yield for 12 month
+111.22 %
1Y
3Y
5Y
10Y
15Y
EOLS
Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California. Address: 520 Newport Center Drive, Newport Beach, CA, United States, 92660
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
23.43 USDP/E ratio
–Dividend Yield
–Current Year
+202 085 000 USD
Last Year
+148 616 000 USD
Current Quarter
+66 909 000 USD
Last Quarter
+59 333 000 USD
Current Year
+135 393 001 USD
Last Year
+92 729 000 USD
Current Quarter
+46 405 000 USD
Last Quarter
+39 857 000 USD
Key Figures EOLS
1 year
3 years
5 years
10 years
EBITDA
-24 641 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-9.36 %
PEG Ratio
–
Return On Equity TTM
-861.68 %
Wall Street Target Price
23.43 USD
Revenue TTM
237 260 000 USD
Book Value
0.31 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
35.6 %
Dividend Yield
–
Gross Profit TTM
92 729 000 USD
Earnings per share
-0.9 USD
Diluted Eps TTM
-0.9 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-22.43 %
Dividend Analytics EOLS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EOLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation EOLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
109.8901
Enterprise Value Revenue
4.5166
Price Sales TTM
4.3772
Enterprise Value EBITDA
-21.4983
Price Book MRQ
53.7711
Financials EOLS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EOLS
For 52 weeks
7.44 USD
17.82 USD
50 Day MA
16.09 USD
Shares Short Prior Month
4 840 889
200 Day MA
13.53 USD
Short Ratio
7.97
Shares Short
4 985 273
Short Percent
8.07 %
BeatStart